![]() |
New breast cancer drug Perjeta (pertuzumab) not recommended by NICE, UK
NICE rejects Perjeta® (pertuzumab) following the Department of Health indecision on funding proposals, calling into question future access when the Cancer Drug Fund ends in January 2014. The Department of Health (DH) could be set to let down thousands of patients with an aggressive form of advanced breast cancer...
More... |
Re: New breast cancer drug Perjeta (pertuzumab) not recommended by NICE, UK
Absolutely outraged that once again a drug is being denied to patients here in the uk!
THIS IS EVEN WORSE NEWS AS THE DRUG FUND SET UP BY THE GOVERNMENT TO PROVIDE ACCESS TO DRUGS NOT CURRENTLY AVAILABLE IS DUE TO END IN 6 MONTHS Ellie |
| All times are GMT -7. The time now is 07:10 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021